BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2689727)

  • 1. [An immunohistochemical study of cutaneous tumors using an antibody to the breast cyst fluid protein (GCDFP-15)].
    Komatsu T
    Nihon Hifuka Gakkai Zasshi; 1989 Aug; 99(9):991-7. PubMed ID: 2689727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An immunohistochemical study of normal sweat glands using an antibody to the breast cyst fluid protein (GCDFP-15)].
    Komatsu T; Tajima S; Nishikawa T
    Nihon Hifuka Gakkai Zasshi; 1989 Aug; 99(9):985-9. PubMed ID: 2689726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemistry of GCDFP-24 and zinc alpha2 glycoprotein in benign sweat gland tumors.
    Mazoujian G
    Am J Dermatopathol; 1990 Oct; 12(5):452-7. PubMed ID: 2244662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
    Wallace ML; Longacre TA; Smoller BR
    Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin.
    Mazoujian G; Margolis R
    Am J Dermatopathol; 1988 Feb; 10(1):28-35. PubMed ID: 2459984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation.
    Ansai S; Koseki S; Hozumi Y; Kondo S
    Am J Dermatopathol; 1995 Jun; 17(3):249-55. PubMed ID: 8599433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical studies of normal sweat glands, sweat gland tumors and extramammary Paget's diseases. II. Immunohistochemical studies of sweat gland tumors and extramammary Paget's diseases].
    Ansai S
    Nihon Hifuka Gakkai Zasshi; 1990 Feb; 100(2):133-46. PubMed ID: 2165191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extramammary Paget's disease--evidence for an apocrine origin. An immunoperoxidase study of gross cystic disease fluid protein-15, carcinoembryonic antigen, and keratin proteins.
    Mazoujian G; Pinkus GS; Haagensen DE
    Am J Surg Pathol; 1984 Jan; 8(1):43-50. PubMed ID: 6198933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gross cystic disease fluid protein-15 in salivary gland tumors.
    Swanson PE; Pettinato G; Lillemoe TJ; Wick MR
    Arch Pathol Lab Med; 1991 Feb; 115(2):158-63. PubMed ID: 1992983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extramammary Paget's disease of the perianal and perineal regions. Evidence of apocrine derivation.
    Merot Y; Mazoujian G; Pinkus G; Momtaz-T K; Murphy GF
    Arch Dermatol; 1985 Jun; 121(6):750-2. PubMed ID: 2408584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ultrastructural localization of gross cystic disease fluid protein (GCDFP-15) in breast epithelium.
    Mazoujian G; Warhol MJ; Haagensen DE
    Am J Pathol; 1984 Aug; 116(2):305-10. PubMed ID: 6205595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases.
    Wong TY; Suster S; Cheek RF; Mihm MC
    Am J Dermatopathol; 1996 Apr; 18(2):124-36. PubMed ID: 8739986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perianal Paget's disease: distinguishing primary and secondary lesions using immunohistochemical studies including gross cystic disease fluid protein-15 and cytokeratin 20 expression.
    Nowak MA; Guerriere-Kovach P; Pathan A; Campbell TE; Deppisch LM
    Arch Pathol Lab Med; 1998 Dec; 122(12):1077-81. PubMed ID: 9870855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid.
    Collette J; Hendrick JC; Jaspar JM; Franchimont P
    Cancer Res; 1986 Jul; 46(7):3728-33. PubMed ID: 3486713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of CD23 in cutaneous non-lymphoid neoplasms.
    Carvalho J; Fullen D; Lowe L; Su L; Ma L
    J Cutan Pathol; 2007 Sep; 34(9):693-8. PubMed ID: 17696916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gross cystic disease fluid protein (GCDFP-15) in the breast: past and present.
    Sapino A; Cassoni P; Bussolati G
    J Biol Regul Homeost Agents; 2000; 14(4):259-62. PubMed ID: 11215813
    [No Abstract]   [Full Text] [Related]  

  • 17. DF3 (CA15-3) antibody as a marker of cutaneous adnexal tumors.
    Yasui S; Ando I; Kukita A; Hino H; Ohara K
    Acta Derm Venereol; 1994 Mar; 74(2):98-100. PubMed ID: 7911637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gross cystic disease fluid protein-15 reactivity in extramammary Paget's disease with and without associated internal malignancy.
    Kohler S; Smoller BR
    Am J Dermatopathol; 1996 Apr; 18(2):118-23. PubMed ID: 8739985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features.
    Mazoujian G; Pinkus GS; Davis S; Haagensen DE
    Am J Pathol; 1983 Feb; 110(2):105-12. PubMed ID: 6130702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contribution of monoclonal antibody D 47 in the study of sweat gland pathology].
    Kanitakis J; Schmitt D; Thivolet J
    Ann Pathol; 1985; 5(1):19-27. PubMed ID: 2990499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.